Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Mar 29;172(7):899-905.
doi: 10.1503/cmaj.045232.

Nonalcoholic fatty liver disease

Affiliations
Review

Nonalcoholic fatty liver disease

Leon A Adams et al. CMAJ. .

Abstract

Nonalcoholic fatty liver disease is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and hepatocellular carcinoma. Current treatment recommendations are limited to weight loss and exercise, although several promising medications are on the horizon. In this article we discuss the etiology, pathogenesis and diagnosis of nonalcoholic fatty liver disease as well as approaches to its management.

PubMed Disclaimer

Figures

None
Fig. 1: Development of nonalcoholic hepatic steatosis. Insulin resistance enhances triglyceride (TG) lipolysis and inhibits esterification of free fatty acids (FFA) within adipose tissue. The result is increased serum FFA levels, which are taken up by the liver. Hepatic TG synthesis is driven by the increased influx of FFA and favoured by insulin upregulated lipogenic transcription factors, such as peroxisome proliferator-activated receptor gamma (PPARγ) and sterol regulatory element binding protein (SREBP)-1c. Alternative metabolism of FFA by oxidation is inhibited by insulin. TG export via very-low-density lipoproteins (VLDL) may be inhibited by decreased synthesis of apolipoprotein B (apo B) or reduced incorporation of TG with apo B by microsomal triglyceride transfer protein (MTP). See the animated figure at www.cmaj.ca/cgi/content/full/172/7/899/DC1. Photo: Mayo Clinic
None
Fig. 2: Left: Histologic features of fibrosis in nonalcoholic steatohepatitis (NASH). Trichrome stain of liver (magnification х 200) demonstrating macrovesicular steatosis and fibrosis, most prominent in zone 3 near the central vein (CV) of the hepatic lobule. Typically early fibrosis is pericellular and perisinusoidal, giving the appearance of “chickenwire.” Right: Histologic features of necrotic inflammation in NASH. Hematoxylin and eosin stain of liver (magnification х 400) with injured ballooned hepatocytes (B) and a mild neutrophilic infiltrate (N). Aggregations of Mallory's hyaline (MH) comprised of eosinophilic cytoskeleton filaments are also observed.

Comment in

  • Nonalcoholic fatty liver disease.
    Madan P. Madan P. CMAJ. 2005 Sep 27;173(7):734-5; author reply 735. doi: 10.1503/cmaj.1050094. CMAJ. 2005. PMID: 16186570 Free PMC article. No abstract available.
  • Nonalcoholic fatty liver disease.
    Mager D, Roberts E. Mager D, et al. CMAJ. 2005 Sep 27;173(7):735; author reply 735. doi: 10.1503/cmaj.1050122. CMAJ. 2005. PMID: 16186572 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31. - PubMed
    1. Browning J, Szczepaniak L, Dobbins R, Nuremberg P, Horton J, Cohen J, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-95. - PubMed
    1. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8:1114-22. - PubMed
    1. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000;132:112-7. - PubMed
    1. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988;27:142-9. - PubMed

Publication types